Navigation Links
Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
Date:7/10/2014

LAVAL, Quebec, July 10, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the sale to Galderma of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in cash, pursuant to the previously announced agreement with Nestle S.A, which recently completed its acquisition of Galderma.

"We are pleased to complete the divestiture of our products to a company that is firmly committed to the aesthetic dermatology market," said J. Michael Pearson, chairman and chief executive officer.  "Humberto Antunes, CEO of Galderma, has embraced our commercial team and I know he will continue our efforts to build strong relationships with the healthcare leaders in this industry."

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Contact Information:

Laurie W. Little
949-461-6002
laurie.little@valeant.com

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
2. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
3. Valeant Pharmaceuticals To Present At Industry Conferences
4. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
5. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
6. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
7. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
8. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
9. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
10. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
11. Valeant Pharmaceuticals Announces Continuance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015   Vincari , ... surgeons , has just hired John O,Neil ... Development. John has over 30 years of diverse and ... Mr. O,Neil,s executive healthcare experience coupled with Vincari,s CMO, ... surgeon allows Vincari to address the challenges both hospitals ...
(Date:7/28/2015)... , July 28, 2015 The ... with the Canadian Anti-Fraud Centre (CAFC), ... falsely using the CIPA verification seal on illegitimate ... of legitimate online pharmacy member companies who have ... medications to more than 10 million Americans since ...
(Date:7/28/2015)... 28, 2015 Baebies, Inc. today announced the ... million. The oversubscribed round of financing included key investors ... endowment), Cunning Capital, Triad, LLC, the Duke Angel Network ... Many of Advanced Liquid Logic,s (ALL) former investors including ... "Rex is pleased to support this ...
Breaking Medicine Technology:John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2
... 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the BofAML 2012 Health Care Conference to be held ... in Las Vegas.  Mr. Adrian Adams, Chief Executive Officer ... the Company and its product pipeline at 11:20 a.m. ...
... May 11, 2012 Remedy Informatics, Inc. further ... science and translational research informatics today with its ... SpecimenTrack™ .  Remedy will offer demonstrations of SpecimenTrack ... Environmental Repositories (ISBER) 2012 Annual Meeting & Exhibit ...
Cached Medicine Technology:Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference 2Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference 3Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference 4Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting 2Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting 3
(Date:7/29/2015)... , ... July 29, 2015 , ... Indiana is known ... is also the home of Zerorez Indianapolis, which plans to expand across the state. ... “2015 is our second full year in business and we should double our first ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... Dermatology, is the first dermatologist in Sarasota to be chosen by the manufacturer ... , “Kybella offers the first injectable, non-invasive way to treat and eliminate double ...
(Date:7/29/2015)... ... July 29, 2015 , ... Hernia repairs have always been common and routine ... by the National Center for Health Statistics indicates that more than five million ... reported annually. While the only effective treatment for a hernia is surgery, only about ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW Dynatec, ... In her role, Powers is responsible for driving growth and innovation across ITW ... “Gina’s track record as an effective leader within the ITW community speaks for ...
(Date:7/28/2015)... , ... July 29, 2015 , ... ... executives, doctors, lawyers and other A-Listers, has evolved into a world class millionaires ... a Millionaire strives to match successful and attractive people seeking real, meaningful and ...
Breaking Medicine News(10 mins):Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2
... from the patient,s leg are used to strengthen weak muscles that can ... ... 2009 -- Urologists at Beaumont Hospital ( http://www.beaumonthospitals.com ) are first in ... stem cells through a research study. The stem cells are used to ...
... portion of spring promotion WHITE PLAINS, N.Y., March 10 ... a partnership with Gap Inc. through its Give & ... research, patient education and support initiatives.LLS is one of ... during the upcoming Give & Get promotion. For three ...
... The Caryl Ehrlich Program Changes Lives with 10-Sessions for ... alternative to dieting that does work. It,s called The ... people view weight loss entirely. Instead of countless diets, ... change habits of thought and word to lose weight ...
... LLC, the industry,s premier health information exchange, ... to President and Chief Operating Officer.(Logo: ... role in health care reform, leveraging our ... health quality and efficiency," said Julie Klapstein, ...
... $3.7 Million Impact on D.C. Breast HealthWASHINGTON, March 10 ... of Susan G. Komen for the Cure(R) joined the Hon. ... the Italian Embassy to officially kick off registration for the ... Cure(R), which will be held on the Washington, D.C. National ...
... MIAMI, March 10 Karen Peterson has been ... VITAS Innovative Hospice Care(R), one of the nation,s ... position, Peterson will have oversight for the interdisciplinary ... programs located throughout the country.Peterson most recently was ...
Cached Medicine News:Health News:Beaumont Launches 1st U.S. Adult Human Stem Cell Study for Stress Urinary Incontinence 2Health News:Gap Inc., The Leukemia & Lymphoma Society Encourage Shoppers to Support Cancer-Fighting Programs 2Health News:Behavioral Approach to Weight Loss 2Health News:Availity Promotes Russ Thomas to President and Chief Operating Officer 2Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 2Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 3Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 4Health News:VITAS Innovative Hospice Care(R) Names Karen Peterson Vice President and Chief Nursing Officer 2
Sinus Trocar and Cannula, 4 mm...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
An air-based corneal esthesiometer that can stimulate subthreshold at corneal apex in normals. Has use in determining corneal physiology, healing, etc. May have application to the measurement of norm...
Kelly Punches...
Medicine Products: